• Sourcing Solutions
  • Services & Membership
  • Help & Community
Business Type: Manufacturer, Trading Company Verified
Location: Sichuan, China (Mainland) Verified
Main Products: Pancreatin, Pepsin, Trypsin-chymotrypsin, Heparin Sodium, Chondroitin Sulphate
Total Employees: 201 - 300 People
Total Annual Revenue: US$10 Million - US$50 Million
Year Established: 2011 Verified
Top 3 Markets: South Asia 20.00% Western Europe 20.00% Eastern Europe 20.00%
Company profile    Sichuan Deebio Pharmaceutical Co., Ltd was established in March of 2011...
Company profile

Sichuan Deebio Pharmaceutical Co., Ltd was established in March of 2011 which is located in Xiaohan town, Guanghan City. In Oct of 2011, Deebio took over the entire Sichuan Deyang Biochemical Products Co., Ltd. The production process is strictly in accordance with the requirements of Chinese GMP as will as European GMP. We have successfully passed the Chinese GMP certification in Sep of 2012; it assured the march to the global pharmaceutical market.
We are a professional enzyme manufacturer and we have made many ultra progress on the research of enzyme products. We always put market at the first place and explore both the civil and global markets. With sufficient raw materials in China, we developed series of animal organ extracts, like Pancreatin, Trypsin-Chymotrypsin, Chymotrypsin, Trypsin, Pancreatic Kininogenase, Pepsin, Elastase, Heparin Na, Cytochrome C, Bovine Liver Extract, Chondroitin Sulfate and other products and we have already established stable and long time cooperation with the customers all around the world and our products are well sold in the U.S, Germany, Japan, South Korean, India, Russia and other countries and areas.
To become a modern and large biological pharmaceutical enterprise is the final target of the developing Deebio. Our aims are: to upgrade the research and manufacturing level of Chinese biological pharmacy, to improve the health condition of people and to apply the latest biological technology to serve the health industry. Finally, we will do every effort to make Deebio as a biogical pharmaceutical enterprise with specialized products, globalized market and standardized management.

Trade Capacity View More >

Trade & Market
Main Markets Total Revenue(%)
South Asia 20.00%
Western Europe 20.00%
Eastern Europe 20.00%
North America 20.00%
Export Percentage: 91% - 100%
No. of Employees in Trade Department: 11-20 People
Email to this supplier